|
ARNT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.145800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.904200E-01 |
| Normal-vs-Stage2 |
8.511200E-01 |
| Normal-vs-Stage3 |
1.558180E-01 |
| Normal-vs-Stage4 |
5.575800E-03 |
| Stage1-vs-Stage2 |
6.189200E-01 |
| Stage1-vs-Stage3 |
4.332200E-01 |
| Stage1-vs-Stage4 |
2.629800E-02 |
| Stage2-vs-Stage3 |
3.612200E-01 |
| Stage2-vs-Stage4 |
9.866400E-02 |
| Stage3-vs-Stage4 |
2.093400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.373000E-01 |
| Normal-vs-AfricanAmerican |
9.798200E-01 |
| Normal-vs-Asian |
7.854800E-01 |
| Caucasian-vs-AfricanAmerican |
7.736600E-01 |
| Caucasian-vs-Asian |
9.074600E-01 |
| AfricanAmerican-vs-Asian |
8.709800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.284400E-01 |
| Normal-vs-Female |
1.964020E-01 |
| Male-vs-Female |
6.943600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.140200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.394300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.136800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.870000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.370010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.874800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.834600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.699200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.220200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.800000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.105620E-02 |
| Classical-VS-Follicular |
2.034200E-02 |
| Classical-VS-Other |
6.209200E-01 |
| Classical-VS-Normal |
9.564400E-01 |
| Tall-VS-Follicular |
3.820600E-01 |
| Tall-VS-Other |
4.701400E-01 |
| Tall-VS-Normal |
1.326110E-02 |
| Follicular-VS-Other |
8.291800E-01 |
| Follicular-VS-Normal |
2.793700E-02 |
| Other-VS-Normal |
3.332000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.576600E-01 |
| Normal-vs-N1 |
1.162280E-02 |
| N0-vs-N1 |
1.420440E-01 |
|
|
